Report: India's Tobacco Consumption Ranks 2nd Globally, 27% Adults

Market by 2FIRSTS.ai
May.06.2024
Report: India's Tobacco Consumption Ranks 2nd Globally, 27% Adults
India ranks as the world's second-largest tobacco-consuming country, with 27% of adults using tobacco, per report by KPMG and ET Edge.

According to a report published by KPMG Insurance and Consulting Services and ET Edge on May 1st, India is the second largest consumer of tobacco globally, with 27% of Indian adults having a tobacco consumption habit. The report highlights the need for a comprehensive roadmap focused on reducing tobacco-induced harm, with diverse and less harmful alternatives to help individuals quit smoking. It is estimated that by 2060, the annual number of deaths globally due to tobacco-related illnesses will decrease by 50%.

 

According to a report, tobacco-related diseases caused over 7 million deaths globally in 2019, with India accounting for 1.35 million of those deaths. The report also showed that 66% of respondents began smoking between the ages of 20-25. Due to lack of alternatives, 45% of respondents were unable to quit smoking or chewing tobacco. The report further stated that only 8% of tobacco consumed is in the form of legally produced cigarettes, with the remaining 92% being cheap tobacco products such as chewing tobacco and khaini. In major cities, stress, anxiety, and emotional distress were identified as the main reasons for smoking.

 

India faces a dilemma as it attempts to implement global tobacco control initiatives while also trying to support a large population of economically vulnerable smokers. On the other hand, reports suggest that India is also grappling with the dual challenge of smoking and smokeless tobacco abuse.

 

A report has pointed out that the impact of tobacco consumption on health and the economy is closely linked. According to the report, 25% of the male population surveyed in second and third-tier cities have health problems, with 29% of cases being severe; while in first-tier cities, 50% of male respondents mentioned having health problems, with 44% of cases being severe.

 

However, due to a lack of awareness of the dangers of tobacco and a lack of alternatives, 81% of male respondents with serious health issues in first-tier cities have not quit smoking. The report predicts that by 2030, 80% of tobacco-related deaths will occur in low- and middle-income countries. Additionally, in India, the early deaths and illnesses caused by tobacco use reduce the country's Gross Domestic Product by 1% annually. Therefore, India may need to adopt effective tobacco control policies to reduce harm and disease burden, as well as support people in quitting smoking.

 

India has already implemented strict regulations to control tobacco consumption and protect public health. The country has enacted tobacco control laws in line with the requirements of the World Health Organization, aiming to regulate the production, sale, and consumption of tobacco products, as well as protect non-smokers from the effects of secondhand smoke. In order to address the challenges posed by tobacco consumption, India has taken several measures, including testing harmful substances and ingredients in tobacco products.

 

Global policies and projects aimed at controlling tobacco use have been upgraded thanks to the participation of various countries. While many countries have complied with the World Health Organization's tobacco control convention, some countries have adopted tailored approaches. The report points out that in countries like Japan, the UK, New Zealand, and Sweden, where there are many less harmful alternatives available, the decline in smoking rates is greater than in countries like India, Australia, and Singapore, where access to less harmful alternatives is limited.

 

The report advocates for changing current practices and shifting towards "tobacco control 3.0," implementing evidence-based tobacco control solutions to achieve a healthier India. The report suggests encouraging those unwilling to quit smoking to switch to less harmful alternatives to reduce their overall health risks.

 

Increasing attention to making nicotine replacement therapy (NRT) more affordable and accessible can further support these individuals in quitting smoking. The report recommends law enforcement agencies develop and maintain comprehensive databases of tobacco product manufacturers and retailers, both on the market and unlisted. Furthermore, investment in technologies such as blockchain should be considered to track illegal trade of tobacco and other prohibited tobacco products.

 

The report also recommends investing in innovation funds to support research, data collection, and impact monitoring. Increasing investment in nationwide mass media campaigns and supporting targeted regional media to educate smokers, dispel misconceptions about tobacco use, and encourage them to support smoking cessation will also play a crucial role.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Japan Tobacco International (JTI) has introduced PERLZ nicotine pearls in the UK, expanding its oral nicotine portfolio beyond conventional nicotine pouches. The fully dissolvable, multi-layer pearls are placed under the tongue and come in Mint and Berry flavors at concentrations of 1mg/g and 2mg/g, equivalent to approximately 0.3mg and 0.5mg of nicotine per pearl. UK retailer Haypp published four 30-pearl dispenser listings on July 31, 2026, followed by three 10-pearl sachet products on August 17. The dispensers retail for £6.50, while the sachets cost £2.50.
product
Oct.12
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20